4//SEC Filing
Deliargyris Efthymios 4
Accession 0001104659-24-043795
CIK 0001175151other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 9:47 PM ET
Size
9.7 KB
Accession
0001104659-24-043795
Insider Transaction Report
Form 4
Deliargyris Efthymios
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-04-02+86,000→ 86,000 totalExercise: $0.95Exp: 2034-04-02→ Common Stock (86,000 underlying) - Award
Common Stock
2024-04-02+61,000→ 409,433 total
Footnotes (6)
- [F1]These shares represent restricted stock units ("RSUs") which shall vest in equal parts at the first and second year anniversaries of the date of grant, subject to the reporting person's continued service as of the applicable vesting date.
- [F2]Includes: (i) the following RSUs, which vest as to two-thirds of the award on the first anniversary of the date of grant and one-third of the award on the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date) that will settle into shares of common stock, par value $0.001 per share (the "Common Stock") upon vesting: 55,000 RSUs granted on July 7, 2023 and unvested as of the date hereof;
- [F3](continued from footnote 2) (ii) the following RSUs that will be settled into Common Stock upon vesting upon a "Change In Control" of the Company as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 120,000 RSUs granted on April 9, 2020 and (b) 55,000 RSUs granted on August 10, 2022;
- [F4](continued from footnote 3) (iii) the following RSUs that will settle into Common Stock upon vesting: (a) 20,000 RSUs granted on April 9, 2020 and unvested on the date hereof (which cliff vest on the fourth anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date) and (b) 17,334 RSUs granted on August 10, 2022 and unvested on the date hereof (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date); and
- [F5](continued from footnote 4) (iv) 81,099 shares of Common Stock owned by the reporting person.
- [F6]These stock options were granted pursuant to the Plan. The shares underlying these stock options vest as to one-half of the award on the first year anniversary of the date of grant, one-fourth of the award on the second year anniversary of the date of grant, and one-fourth of the award on the third year anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001751617
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 9:47 PM ET
- Size
- 9.7 KB